Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan.
作者信息
Uyama Yoshiaki, Shibata Taro, Nagai Naomi, Hanaoka Hideki, Toyoshima Satoshi, Mori Kazuhiko
机构信息
Pharmaceuticals and Medical Devices Agency and Statistics and Cancer Control Division, National Cancer Center, Tokyo, Japan.
出版信息
Clin Pharmacol Ther. 2005 Aug;78(2):102-13. doi: 10.1016/j.clpt.2005.04.001.
PMID:16084844
Abstract
摘要
Zotero 插件